The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2014

Filed:

Nov. 11, 2009
Applicants:

Anatoly Kachurin, Orlando, FL (US);

Olga Kachurina, Orlando, FL (US);

Vaughan Wittman, Oviedo, FL (US);

Tenekua Tapia, Orlando, FL (US);

Inventors:

Anatoly Kachurin, Orlando, FL (US);

Olga Kachurina, Orlando, FL (US);

Vaughan Wittman, Oviedo, FL (US);

Tenekua Tapia, Orlando, FL (US);

Assignee:

Sanofi Pasteur Vaxdesign Corp., Orlando, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 39/42 (2006.01); A61K 39/12 (2006.01); A61K 45/00 (2006.01); C12Q 1/70 (2006.01); G01N 33/53 (2006.01); C12Q 1/02 (2006.01); C12N 7/00 (2006.01); G01N 21/76 (2006.01); A61K 49/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention comprises rugged, inexpensive, reliable, and sensitive laboratory assays of antibody-based viral neutralization activity and antibody-based viral adherence inhibition activity. The assays use inactivated, fluorescently-labeled virus, allowing the tests to be performed without extensive safety precautions. The interaction of the labeled virus with target cells is monitored using flow cytometric methods. A preferred embodiment uses simple and inexpensive flow cytometry methodologies and equipment, such as bead array readers used as simplified flow cytometers. The assays are rapid, taking no longer than a few hours and are readily conducted by a trained technician. The assays are sensitive because they use labeled viruses at low concentrations and determine neutralizing and blocking capacity of sera and antibody at low concentrations. The methods are appropriate for high-throughput screening of large panels of samples.


Find Patent Forward Citations

Loading…